Nevertheless, FTLD-TDP types A and B, Tau-positive frontotemporal lobar degeneration (FTLD-tau) and Alzheimer’s disease (AD) have been reported in 17% to 32% of patients with SD [6, 64, 66, 67]. The gene discussed is MAPT; the disease is Alzheimer disease.